Evidence-Based Medicine Guidelines
Beta-blockers as second-line therapy for primary hypertension
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Beta-blockers as Second-line Therapy for Primary Hypertension." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457052/all/Beta_blockers_as_second_line_therapy_for_primary_hypertension.
Beta-blockers as second-line therapy for primary hypertension. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/457052/all/Beta_blockers_as_second_line_therapy_for_primary_hypertension. Accessed May 13, 2025.
Beta-blockers as second-line therapy for primary hypertension. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/457052/all/Beta_blockers_as_second_line_therapy_for_primary_hypertension
Beta-blockers as Second-line Therapy for Primary Hypertension [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 May 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457052/all/Beta_blockers_as_second_line_therapy_for_primary_hypertension.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Beta-blockers as second-line therapy for primary hypertension
ID - 457052
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457052/all/Beta_blockers_as_second_line_therapy_for_primary_hypertension
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
